The U.S. is expected to lose its official measles elimination status after a review by the Pan American Health Organization this week. More than 5,100 measles cases have been reported nationwide in 2026 as of early November, the country's worst outbreak in more than three decades, according to the report.

Eight measles-associated deaths have been confirmed by states so far in 2026: six in Pennsylvania, one in New York and one in Wisconsin.

A new tool developed by researchers at Johns Hopkins University estimates the 2026 outbreaks have cost nearly $83 million. That total includes $56 million in public health response costs, almost $25 million in lost productivity and more than $1.8 million in direct medical expenses. The tool also estimates that 2025 outbreaks, which involved 2,289 confirmed cases, cost more than $37 million.

The researchers say the figures are not a definitive accounting of actual costs. The tool uses state-specific cost and financing data and builds on an August study by the same researchers that relied on historical outbreak costs.

Costs vary by state. The tool estimates the 48 cases New York reported in 2025 carried about $1.1 million in costs. It estimates the 803 cases in Texas, the epicenter of the largest U.S. outbreak in 2025, carried nearly $13 million.

Bryan Patenaude, a health economist at the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health who helped develop the tool, said in an interview with CNBC: "We're starting to see a whole bunch of people who decided not to get vaccinated as kids or have never gotten exposed to measles because they benefited from herd immunity, who now make it into adulthood and risk potentially getting quite seriously ill and requiring very significant medical expenses, or dying at the hospital."

Patenaude said much of the cost is incurred up front. "It's a largely labor-driven cost," he said, citing contact tracing and mobilizing multiple agencies.